Synthetic peptide vaccine targeting a cryptic neutralizing epitope in domain 2 of Bacillus anthracis protective antigen.
about
Protective immunity against Trichinella spiralis infection induced by a multi-epitope vaccine in a murine model.Identification and validation of a linear protective neutralizing epitope in the β-pore domain of alpha toxin.Epitope-focused peptide immunogens in human use adjuvants protect rabbits from experimental inhalation anthrax.Anthrax vaccine recipients lack antibody against the loop neutralizing determinant: A protective neutralizing epitope from Bacillus anthracis protective antigen.Human monoclonal antibodies generated following vaccination with AVA provide neutralization by blocking furin cleavage but not by preventing oligomerizationRecombinant vaccine displaying the loop-neutralizing determinant from protective antigen completely protects rabbits from experimental inhalation anthraxStochastic humoral immunity to Bacillus anthracis protective antigen: identification of anti-peptide IgG correlating with seroconversion to Lethal Toxin neutralizationA heterologous helper T-cell epitope enhances the immunogenicity of a multiple-antigenic-peptide vaccine targeting the cryptic loop-neutralizing determinant of Bacillus anthracis protective antigen.Anthrax vaccines: present status and future prospects.Multiple antigen peptide mimetics containing gp41 membrane-proximal external region elicit broad neutralizing antibodies against human immunodeficiency virus type 1 in guinea pigs.Identification of a Continuous Neutralizing Epitope within UL128 of Human Cytomegalovirus.The promise and challenge of epitope-focused vaccines.An epitope of Bacillus anthracis protective antigen that is cryptic in rabbits may be immunodominant in humansIn Silico Designed Axl Receptor Blocking Drug Candidates Against Zika Virus Infection.
P2860
Q35018796-C39C1783-2631-4744-B846-D25E98A4847EQ35031839-C406A7E9-2842-404D-9F96-5DBEB7D44882Q35341887-19490729-7F6D-46DE-A477-C58A813F8E22Q35900460-E33B99DC-8BF0-4457-A205-2FA98B9B1000Q36007463-D7B1D241-8028-4AF3-8F5E-3DA7DB9809ADQ36668524-C296585F-83F0-4BD8-9D7E-E71F37308DD8Q36733960-DF610CBA-CBB3-4B91-BB16-8BE36457B3BDQ37451219-6E55E52F-29FA-4241-A012-67E091046665Q38132268-6C1D0538-5DC3-4151-BD08-57002A6398DDQ39136039-84B5B506-E752-4A71-B0EA-549047F92496Q40375876-28F14120-0A6B-418C-BB02-60FA884858E8Q40722956-70117130-12A0-49D8-8780-BEC5894294C9Q42707870-E0260CB2-B4A3-4C66-B5B6-A1BEA00A81C9Q55669574-89F9B2EA-7555-48E2-AF4D-27685430895D
P2860
Synthetic peptide vaccine targeting a cryptic neutralizing epitope in domain 2 of Bacillus anthracis protective antigen.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Synthetic peptide vaccine targ ...... anthracis protective antigen.
@en
Synthetic peptide vaccine targ ...... anthracis protective antigen.
@nl
type
label
Synthetic peptide vaccine targ ...... anthracis protective antigen.
@en
Synthetic peptide vaccine targ ...... anthracis protective antigen.
@nl
prefLabel
Synthetic peptide vaccine targ ...... anthracis protective antigen.
@en
Synthetic peptide vaccine targ ...... anthracis protective antigen.
@nl
P2093
P2860
P356
P1476
Synthetic peptide vaccine targ ...... anthracis protective antigen.
@en
P2093
Jana L Jacobs
Jon Oscherwitz
Kemp B Cease
Philip R Johnson
Te-Hui Liu
P2860
P304
P356
10.1128/IAI.00358-09
P407
P577
2009-06-01T00:00:00Z